Maolong Wang

524 total citations
18 papers, 379 citations indexed

About

Maolong Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maolong Wang has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maolong Wang's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Maolong Wang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Maolong Wang collaborates with scholars based in China and United States. Maolong Wang's co-authors include Wenjie Jiao, Xiao Sun, Yuling Yang, Yong Sun, Bin He, Yan Liang, Keqi Chen, Mengdi Wang, Xiaohui Zhan and Jianqin Yan and has published in prestigious journals such as ACS Applied Materials & Interfaces, Nanoscale and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Maolong Wang

18 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maolong Wang China 10 222 157 59 54 47 18 379
Danbi Seo South Korea 4 178 0.8× 123 0.8× 47 0.8× 47 0.9× 67 1.4× 6 328
Ruixin Wang China 13 249 1.1× 124 0.8× 30 0.5× 54 1.0× 58 1.2× 39 444
Yudan Xie China 8 188 0.8× 102 0.6× 27 0.5× 16 0.3× 22 0.5× 12 298
Zijie Mei China 10 216 1.0× 91 0.6× 41 0.7× 31 0.6× 54 1.1× 27 355
Yonglong Jin China 14 209 0.9× 101 0.6× 40 0.7× 36 0.7× 44 0.9× 29 473
Fubo Zhou China 5 148 0.7× 72 0.5× 46 0.8× 41 0.8× 41 0.9× 6 323
Shufang Ning China 10 205 0.9× 137 0.9× 19 0.3× 32 0.6× 70 1.5× 25 367
Judong Luo China 11 256 1.2× 82 0.5× 32 0.5× 49 0.9× 90 1.9× 21 450
Yang Cong China 9 174 0.8× 59 0.4× 29 0.5× 45 0.8× 133 2.8× 26 373

Countries citing papers authored by Maolong Wang

Since Specialization
Citations

This map shows the geographic impact of Maolong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maolong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maolong Wang more than expected).

Fields of papers citing papers by Maolong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maolong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maolong Wang. The network helps show where Maolong Wang may publish in the future.

Co-authorship network of co-authors of Maolong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Maolong Wang. A scholar is included among the top collaborators of Maolong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maolong Wang. Maolong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Mengdi, Zhuoran Zhang, Maolong Wang, et al.. (2022). Targeted Polymeric Nanoparticles Based on Mangiferin for Enhanced Protection of Pancreatic β-Cells and Type 1 Diabetes Mellitus Efficacy. ACS Applied Materials & Interfaces. 14(9). 11092–11103. 29 indexed citations
3.
Wang, Maolong, Yuling Yang, Chuan Li, et al.. (2021). Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR‐578. Thoracic Cancer. 12(16). 2258–2264. 17 indexed citations
4.
Yan, Jianqin, Xiaohui Zhan, Zhuangzhuang Zhang, et al.. (2021). Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects. Journal of Nanobiotechnology. 19(1). 412–412. 75 indexed citations
5.
Onaitis, Mark W., Yandong Zhao, Yunpeng Xuan, et al.. (2021). Risk of Acute Lung Injury after Esophagectomy. Seminars in Thoracic and Cardiovascular Surgery. 34(2). 737–746. 3 indexed citations
6.
Wang, Yuanyong, et al.. (2021). GAS6-AS1 Overexpression Increases GIMAP6 Expression and Inhibits Lung Adenocarcinoma Progression by Sponging miR-24-3p. Frontiers in Oncology. 11. 645771–645771. 11 indexed citations
7.
Li, Han, et al.. (2021). Detection of Prognostic Biomarkers for Hepatocellular Carcinoma through CircRNA-associated CeRNA Analysis. Journal of Clinical and Translational Hepatology. 10(1). 80–89. 7 indexed citations
8.
Wang, Mengdi, Yan Liang, Keqi Chen, et al.. (2021). The management of diabetes mellitus by mangiferin: advances and prospects. Nanoscale. 14(6). 2119–2135. 39 indexed citations
9.
Nie, Pei, Guangjie Yang, Ning Wang, et al.. (2020). Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 217–230. 50 indexed citations
10.
Nie, Pei, Guangjie Yang, Ning Wang, et al.. (2020). Correction to: Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 325–327. 5 indexed citations
12.
Wang, Maolong, et al.. (2019). Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies. Translational Cancer Research. 8(7). 2636–2653. 9 indexed citations
13.
Wang, Maolong, et al.. (2019). Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies. Translational Cancer Research. 8(7). 2636–2653. 21 indexed citations
14.
Sun, Xiao, Maolong Wang, Rongjian Xu, et al.. (2019). Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma. Translational Lung Cancer Research. 8(6). 907–919. 14 indexed citations
15.
Wang, Maolong, Xiao Sun, Yuling Yang, & Wenjie Jiao. (2018). Long non‐coding RNA OIP5‐AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR‐378a‐3p. Thoracic Cancer. 9(8). 939–949. 65 indexed citations
16.
Sun, Xiao, Maolong Wang, Shicheng Li, et al.. (2018). Overexpression of long non‐coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non‐small cell lung cancer. Thoracic Cancer. 9(5). 523–531. 23 indexed citations
17.
Wang, Maolong, et al.. (2012). [Clinical study on risk factor associated with gut flora change in patients with rectal cancer during perioperative period].. PubMed. 15(6). 570–3. 3 indexed citations
18.
Liu, Hancheng, et al.. (2012). [Effect of different perioperative treatments on gut flora in SD rats].. PubMed. 15(6). 581–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026